SEARCH

SEARCH BY CITATION

References

  • 1
    Matteoni C, Younossi ZM, McCullough A. Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity. Gastroenterology 1999; 116: 14131419.
  • 2
    Day CP, James OFW. Hepatic steatosis: innocent bystander or guilty party? HEPATOLOGY 1998; 27: 14631466.
  • 3
    Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, Mason A, et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab 2006; 3: 321331.
  • 4
    Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease. HEPATOLOGY 2007; 46: 10811090.
  • 5
    Vance DE. Phospholipid biosynthesis in eukaryotes. In: Vance DE, Vance JE, eds. Biochemistry of Lipids, Lipoproteins and Membranes. 5th ed. New York: Elsevier; 2008: 213244.
  • 6
    DeLong CJ, Shen YJ, Thomas MJ, Cui Z. Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway. J Biol Chem 1999; 274: 2968329688.
  • 7
    Tang W, Keesler GA, Tabas I. The structure of the gene for murine CTP:phosphocholine cytidylyltransferase, Ctpct. J Biol Chem 1997; 272: 1314613151.
  • 8
    Karim M, Jackson P, Jackowski S. Gene structure, expression and identification of a new CTP:phosphocholine cytidylyltransferase [beta] isoform. Biochim Biophys Acta 2003; 1633: 112.
  • 9
    Noga AA, Vance DE. A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice. J Biol Chem 2003; 278: 2185121859.
  • 10
    Jacobs RL, Devlin C, Tabas I, Vance DE. Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins. J Biol Chem 2004; 279: 4740247410.
  • 11
    Jacobs RL, Zhao Y, Koonen DPY, Sletten T, Su B, Lingrell S, et al. Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity. J Biol Chem 2010; 285: 2240322413.
  • 12
    Song J, da Costa KA, Fischer LM, Kohlmeier M, Kwock L, Wang S, et al. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J 2005; 19: 12661271.
  • 13
    Veteläinen R, van Vliet A, Gouma D, van Gulik T. Steatosis as a risk factor in liver surgery. Ann Surg 2007 245: 2030.
  • 14
    Angulo P. Nonalcoholic fatty liver disease and liver transplantation. Liver Transplant 2006; 12: 523534.
  • 15
    Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 12491253.
  • 16
    Higgins HM, Andersen RM. Experimental pathology of liver: restoration of liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186202.
  • 17
    Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 24672474.
    Direct Link:
  • 18
    Brunt EM, Kleiner DE, Wilson LA, Unalp A, Behling CE, Lavine JE, et al. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD—clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. HEPATOLOGY 2009; 49: 809820.
  • 19
    Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. HEPATOLOGY 2005; 41: 13131321.
  • 20
    Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497509.
  • 21
    Rouser G, Siakotos AN, Fleishcher S. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids 1966: 8586.
  • 22
    Snyder F, Stephens N. A simplified spectrophotometric determination of ester groups in lipids. Biochim Biophys Acta 1959: 244245.
  • 23
    Waite KA, Cabilio NR, Vance DE. Choline deficiency-induced liver damage is reversible in Pemt−/− mice. J Nutr 2002; 132: 6871.
  • 24
    Jezek P. Possible physiological roles of mitochondrial uncoupling proteins—UCPn. Int J Biochem Cell Biol 2002; 34: 11901206.
  • 25
    Ockner RK. Metabolism and gene expression in liver regeneration. In: Integration of Metabolism, Energetics, and Signal Transduction. 1st ed. New York: Springer; 2004: 177190.
  • 26
    Ridgway ND, Yao Z, Vance DE. Phosphatidylethanolamine levels and regulation of phosphatidylethanolamine N-methyltransferase. J Biol Chem 1989; 264: 12031207.
  • 27
    Walkey CJ, Donohue LR, Bronson R, Agellon LB, Vance DE. Disruption of the murine gene encoding phosphatidylethanolamine N-methyltransferase. Proc Natl Acad Sci U S A 1997; 94: 1288012885.
  • 28
    Haines D, Rose C. Impaired labelling of liver phosphatidylethanolamine from ethanolamine-14C in choline deficiency. Can J Biochem 1970; 48: 885892.
  • 29
    Kumar VV. Complementary molecular shapes and additivity of the packing parameter of lipids. Proc Natl Acad Sci U S A 1991; 88: 444448.
  • 30
    Phillips R, Ursell T, Wiggins P, Sens P. Emerging roles for lipids in shaping membrane-protein function. Nature 2009; 459: 379385.
  • 31
    Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006; 6: 128.
  • 32
    Serviddio G, Bellanti F, Tamborra R, Rollo T, Romano AD, Giudetti AM, et al. Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model. Eur J Clin Invest 2008; 38: 245252.
  • 33
    Kojima H, Sakurai S, Uemura M, Fukui H, Morimoto H, Tamagawa Y. Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis. Alcohol Clin Exp Res 2007; 31: S61S66.
  • 34
    Chavin KD, Yang S, Lin HZ, Chatham J, Chacko VP, Hoek JB, et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 1999; 274: 56925700.
  • 35
    Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 2004; 4: 686693.
  • 36
    He S, Atkinson C, Evans Z, Ellett JD, Southwood M, Elvington A, et al. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury. J Immunol 2009; 183: 47644772.
  • 37
    Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 18981906.
  • 38
    Wunderlich FT, Ströhle P, Könner AC, Gruber S, Tovar S, Brönneke HS, et al. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab 2010; 12: 237249.
  • 39
    Buchman A, Ament M, Sohel M, Dubin M, Jenden D, Roch M, et al. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. JPEN J Parenter Enteral Nutr 2001; 25: 260268.
  • 40
    Best CH, Hartroft WS, Lucas CC, Ridout JH. Liver damage produced by feeding alcohol or sugar and its prevention by choline. Br Med J 1949; 2: 10011006.
  • 41
    Detopoulou P, Panagiotakos DB, Antonopoulou S, Pitsavos C, Stefanadis C. Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study. Am J Clin Nutr 2008; 87: 424430.